Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients

Ke He*, Jun-Cheng Shi*, Xiao-Ming Mao Department of Endocrinology, Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing, People's Republic of China *These authors contributed equally to this work Abstract: Acarbose is an α-glucosidase inhibitor that is commo...

Full description

Bibliographic Details
Main Authors: He K, Shi JC, Mao XM
Format: Article
Language:English
Published: Dove Medical Press 2014-06-01
Series:Therapeutics and Clinical Risk Management
Online Access:http://www.dovepress.com/safety-and-efficacy-of-acarbose-in-the-treatment-of-diabetes-in-chines-a17416